Peptide nanofibres as molecular transporters: From self-assembly to in vivo degradation by Mazza, Mariarosa et al.
Peptide nanofibers as molecular transporters: from self-
assembly to in vivo degradation 
 
Mariarosa Mazza,ab Avnish Patel,a Ramon Pons,c Cyrill Bussyab and Kostas 
Kostarelos*ab 
 
aUCL School of Pharmacy, University College London, Brunswick Square, London WC1N 1AX, UK. 
E-mail: k.kostarelos@ucl.ac.uk 
bSchool of Medicine & National Graphene Institute, Faculty of Medical & Human Sciences, The 
University of Manchester, AV Hill Building, Manchester M13 9NT, UK 
cInstitut de Química Avançada de Catalunya, IQAC-CSIC, Jordi Girona 18–26, 08034 Barcelona, 
Spain 
 
Peptide nanofibers (PNFs) have gained increasing interest as engineered 
biomaterials for drug delivery and tissue repair because of the versatility in design 
they offer through the self-assembly of amphiphilic peptide molecules. Their self-
assembly is governed by hydrophobic interactions and hydrogen bonds between 
peptide sequences able to form b-sheets. In this report, we describe the self-
assembly of PNFs by using palmitoylpeptide molecules containing two different 
cationic amino acid sequences and offer a description of the nanofiber 
physicochemical characteristics. The structural degradation of these PNFs in 
physiologically-relevant media was evaluated experimentally and two mechanisms 
are proposed. We also piloted the tracking of PNFs intracellularly in vitro, upon 
interaction with primary neuronal cultures, and intracranially in vivo, after 
stereotactic administration deep within the brain using two types of fluorescent 
labelled PNFs. Overall, the self-assembled PNFs were seen to internalise within 
neurons and be removed or degrade in the brain. Further work is needed to 
determine the utility of such PNFs as molecular transporters within neuronal tissue. 
Introduction 
 
Peptide nanofibers (PNFs) are high axial ratio nanosized structures mimicking the 
size and shape of various naturally occurring nanoparticulate objects, i.e. viral 
capsids, actin cytoskeletons, and amyloid fibrils. PNFs can be formed by the self-
assembly of peptides and peptide amphiphiles as self-assembly is a 
thermodynamically favourable event in aqueous environments. PNFs are versatile 
supramolecular architectures with potential as molecular transporters. Their 
building blocks can be designed to possess different functionalities resulting in 
chemical and physical properties tailored to specific needs. 
The rational design of PNFs has to take into account several parameters that will 
influence the formation of high axial ratio nanostructures. Stupp and coworkers 
have designed many peptide amphiphiles having a palmitic moiety attached to the 
N-terminus of the peptide sequence conferring a surfactant-like architecture to the 
molecules. The same strategy has been adopted in this work enabling peptide self-
assembly into nanofibers. Similar nanofibers have found a wide range of 
applications as biomaterials for tissue engineering.1,2 Zhang and coworkers have 
developed peptide amphiphiles that are made of amino acids by alternating alanine 
residues in such a way that they pack with inter-digitated hydrophobic interactions 
in a similar fashion as occurs for alanine sequences in silk fibroin.3,4 Other classes 
of peptide amphiphiles have been synthesized by varying the length of the alkyl 
chain.5–7 
At the molecular level, parameters that need fine tuning in order to achieve the 
formation of PNFs include the hydrophobic domain, the hydrophilic block and a 
linker region of b-sheet forming peptides. The hydrophobic block can be 
represented by hydrophobic amino acids or alternatively a hydrophobic tail, often 
being represented by long acyl chains. The hydrophilic block is a sequence of 
basic or/and acid amino acids, often embedded within a biologically active peptide 
sequence. The linker region of b-sheet forming peptides contributes to the 
formation of elongated structures versus spherical micelles that most surfactant 
would form by self-assembling. Furthermore, the presence of aromatic side chain 
amino acids can determine the formation of cylindrical, ribbon like, twisted single or 
multiple fibers via the formation of π-π stacking. All of these parameters can give 
rise to a combination of factors that will influence the physicochemical 
characteristics of the resulting fibers as well as the interactions between nanofibers 
and other biological constituents. 
In this work we report the formation of PNFs by two peptide molecules with 
emphasis on the structural disassembly of the nanofibers in physiological 
environments, as a result of the interaction between nanofibers and enzymes with 
possible degradation activities. We observed the self-assembly and characterized 
the PNFs formed. Their internalization within primary neuron cultures was 
determined by fluorescence microscopy. The in vivo localisation and structural 
stability of the PNFs were investigated following stereotactic administration in the 
brain parenchyma non-invasively using an IVIS camera. 
 
Materials and methods 
 
Preparation of PNFs 
 
Peptides (palmitoyl-GGGAAAR and palmitoyl-GGGAAAKRK) were custommade 
by Peptide Synthetics (Cambridge, UK) as freeze-dried powders at 95% purity. 
PNFs were prepared from a dispersion of 1 mg mL-1 peptide amphiphile in 5% 
dextrose (pH = 6.4) filtered through a 0.22 micron Millipore membrane filter. The 
final pH of the samples was 3.9–4.0, as both K and R are basic residues (R pKa = 
12; K pKa = 10.4)8 and thus bear a positive charge on the ionisable groups of the 
side chain. The dispersions were subject to 5min of probe sonication at 20% of the 
maximum amplitude alternated with pulsed sonication of 20 s each. 
 
Preparation of Fluorescent labelled PNFs 
 
PNF conjugation with fluorescent probe VivoTag 680. VivoTag 680 XL 
(absorbance at 688 ± 5 nm; Perkin Elmer) was reconstituted with 1 mL DMSO. A 1 
mg mL-1 suspension was made using the freeze-dried peptide and phosphate 
buffered saline. This suspension was transferred into an amber Eppendorf tube to 
protect it from light. 50 µL of 1 M sodium bicarbonate and 2 µL of VivoTag 680 XL 
in DMSO were added. The tubes were maintained under constant agitation in a 
Tissuelyser (Qiagen) and set to oscillate 15 times per second for 2 h. The 
suspension was then centrifuged at 12 000 rpm for 4 min. The supernatant which 
contained unreacted dye was removed and discarded. The pellet was resuspended 
in 500 µL of distilled water which was filter sterilised by a 0.22 µm cellulose acetate 
syringe filter. The tubes were then centrifuged at 12 000 rpm for 4 min after which 
the supernatant was removed along with any remaining unreacted dye. The pellet 
was finally resuspended in filter sterilised dextrose 5% (w/v) giving a final 
concentration of 1 mg mL-1. The prepared samples were then bath sonicated for 5 
min using the pulse function, 15 s on and 5 s off. The samples were stored at 4 °C 
until needed. 
Labelling PNFs non-covalently with Nile Red. An ethanol solution of Nile Red (1 
mg mL-1) was added dropwise to PNFs (1 mg mL-1) in 5% dextrose during the 
probe sonication step to obtain a final v/v ratio of 1 : 9. The excess ethanol was 
eliminated by solvent evaporation while stirring the suspension overnight. 
 
Transmission electron microscopy 
 
TEM was performed using a Phillips Biotwin CM 210 electron microscope. 1% 
uranil acetate was used to counterstain the PNFs. For the degradation experiments 
90 µL of either MEM, 0.05% trypsin–EDTA or rat plasma–PBS (1 : 1) was vortex 
mixed with 10 µL of PNFs in 5% dextrose. The samples were placed in a shaking 
incubator at 37 °C. Each sample was imaged at the following time points: 0, 0.5, 
24, 48 h and after two weeks of incubation. The samples were prepared by 
transferring 10 µL onto a 300 grid copper mesh, and the drop was allowed to 
adsorb on top of the mesh for 10 s, after which the excess was wicked off using the 
edge of a filter disc. Uranyl acetate 1% (w/v) was used as a negative contrast 
agent, and was applied to the mesh, allowed to stand for approximately 5 s and 
then removed using the edge of a filter disc. The copper grid was then loaded for 
imaging. PNF lengths were measured for each time point using Image J to perform 
the semiquantitative image analysis. 
 
Small angle X-ray scattering 
 
Small-angle X-ray scattering (SAXS) measurements were carried out using a S3-
MICRO (Hecus X-ray systems GMBH Graz, Austria) coupled to a GENIX-Fox 3D 
X-ray source (Xenocs, Grenoble), which provided a detector focused X-ray beam 
with a λ = 0.1542 nm Cu Kα-line with more than 97% purity and less than 0.3% Kα. 
Scattering of the transmission was detected using a PSD 50 Hecus. Temperature 
was controlled by means of a Peltier TCCS-3 Hecus. The samples were inserted in 
a flow-through glass capillary 1 mm diameter with 20 µm wall thickness. The SAXS 
scattering curves are shown as a function of the scattering vector modulus,  
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where θ is the scattering angle. The q values with our setup ranged from 0.08 nm-1 
to 6.0 nm-1. The system scattering vector was calibrated by measuring a standard 
silver behenate sample. Because of the use of a detector focused small beam (300 
x 400 µm full width at half maximum) the scattering curves were mainly smeared 
by the detector width. This mainly produced a widening of the peaks without a 
noticeable effect on the peak position. The scattering curves for liquid samples 
have been background subtracted and put onto an absolute scale  by comparison 
with the scattering of a water sample.9,10 
The instrumentally smeared experimental SAXS curves were fitted to numerically 
smeared models for the beam size and detector width effects. A least squares 
routine based on the Levenberg–Marquardt scheme was used. Spherical and 
cylindrical models were fitted using two shell models.11,12 
 
Degradation in plasma measured using UV-vis 
 
Fluorescently labelled KRK PNFs were incubated in rat plasma–PBS (1 : 1), 
incubated at 37 °C under constant agitation in a water bath. UV absorbance 
measured using a Cary Bio 50 at different time points (0, 30 min, 1 h, 3 h, 6 h, 24 
h, 2, 4, 7 and 10 days). The UV-vis spectrophotometer was set to measure the 
absorbance of light between 500 and 1000 nm, with data captured at 5 nm 
intervals. A blank was used to set a baseline before measuring the samples. After 
time 0 all samples, including blanks, were placed into a shaking water bath at 37 
°C. All measurements were performed in a black 6Q quartz cuvette (Starna 
Scientific Ltd) with a path length of 1 cm. KRK PNFs were quantified by a mean 
calibration curve. All samples were measured in triplicate.  
 Cell uptake of PNFs 
 
Primary neuronal cell cultures. Cell culture reagents (PBS, HBSS, trypsin, foetal 
bovine serum, DMEM:F12, neurobasal, B27, antibiotics) were purchased from 
Gibco (Life Technologies, UK). Neuron enriched cell cultures were prepared with 
hippocampus extracted from E16–E18 Wistar foetal rat brains (standard Witschi 
stages 33–34). Hippocampal tissue pieces were dissociated to single cell 
suspensions by trypsinization followed by mechanical trituration in Ca2+/Mg2+ free 
HBSS solution. After determination of the number of live cells, 50 000 cells per well 
were plated onto a poly-D-lysine (50 µg ml-1) coated glass bottom 8 well chamber 
slide (Millicell EZ SLIDE, Merck-Millipore) with DMEM:F12 medium completed with 
12% heat inactivated foetal bovine serum and incubated at 37 °C in a humidified 
5% CO2 incubator. After 12 h, the medium was changed to serum free Neurobasal 
Medium supplemented with B27, glutamine (0.5 mM), penicillin (100 U), and 
streptomycin (100 µg). B27 supplement was used as a means to reduce glial cells 
growth and to obtain a nearly pure neuronal cell culture. Cultures were incubated in 
a humidified 37 °C/5% CO2 incubator for 10 days before experimentation. Half of 
the medium was changed every 3 days. Primary neurons were exposed to the 
PNF–Nile Red formulations for 24 hours and the fluorescence was recorded using 
a Zeiss Axiovision Fluorescence Microscope. 
 
Intracranial injection in mice 
 
All experiments were performed in accordance with the approved 
recommendations and policies of the UK Home Office (Animal Scientific 
Procedures Act 1986, UK). Athymic nude mice (8 weeks old, Harlan, UK) were 
used for the in vivo experiments. Anaesthesia was induced by inhalation of 
isoflurane. 1 µL of fluorescently labelled KRK PNFs (1 mg mL-1) was injected 
intracranially using a stereotactic frame. The stereotactic coordinates were: 0.1 mm 
posterior to the bregma, 2.3 mm to the right of the midline and 3 mm below the 
surface of the brain to target the caudate–putamen area of the brain. During 
surgical procedures, the animals were oxygenated and heated to ensure a 37 °C 
rectal temperature. After recovery, the animals were returned to their cages. 
 
IVIS imaging 
 
The fluorescence signal from the KRK PNFs labelled with VivoTag 680 XL in the 
brain was measured using an IVIS Lumina fluorescent imager (Caliper Life 
Sciences) with excitation at 675 nm and emission filter sets 700–840 nm. 
 
Results and discussion 
PNFs form as a result of the self-assembly of amphiphilic peptides. Although 
selfassembly is a thermodynamically favourable process, the time for the formation 
of these supramolecular structures has been shown to vary, from days to weeks for 
similar designer peptides and the nanofibril formation can take days or weeks to 
get to completion. It was recently reported that upon dissolution in ultrapure water 
of a hexapeptide amphiphile bearing aromatic side chain groups, short twisted 
bilayer ribbon segments were observed to be the dominant morphology after only 
30 s, which then elongate on the time scale of minutes, and finally transform into 
helical ribbons over the course of weeks.13,14 Under the same conditions, a similar 
peptide lacking aromatic side chains was shown to form cylindrical nanoparticles 
and not undergo any transition over a period of weeks.14 Thus self-assembly may 
not only occur over a relatively long time, resulting in nanofiber formation, but there 
may also be a transition through metastable nanostructures before maturation into 
the equilibrated morphology. For such reasons, here we used a fast bottom 
approach to self-assembly for the preparation of PNFs. By employing probe 
sonication we reduced to a few minutes the time needed for the self-assembly 
process to take place. As previously reported by Mazza et al.,15 this strategy can be 
employed to prepare an aqueous dispersion of short nanofibers below one micron 
(length range). PNFs were prepared by using two designer peptide amphiphiles in 
isotonic media (5% dextrose) at a concentration of 1 mg mL-1 and as a result of 
sonication we could observe by TEM the formation of cylindrical nanofibers as 
depicted in Fig.1A, C and D, F. 
For both peptides under investigation in the present work we chose a palmitoyl 
chain as the hydrophobic block. Peptide and protein palmitoylation has been 
previously exploited to synthesize lipid derivatives16 intended to increase 
membrane permeation. Unmodified peptides and proteins are generally poorly 
transported across biological membranes due to their hydrophilic nature, their high 
molecular weight and their instability to enzymatic degradation. Such palmitoylation 
strategies have been employed to increase the biological half-life of therapeutic 
peptide molecules.17 The covalent linkage of the C16 chain was designed to 
achieve a change in the physical properties of the peptide, enabling its self-
assembly into high axial ratio nanostructures, as reported in the literature. 2,18,19 We 
then selected a short sequence of 6 amino acids able to form a b-sheet as a linker. 
Several reports have suggested that five is the minimum number of residues to 
include in a sequence in order to form a sequence capable of forming b-sheets for 
palmitoylated peptide amphiphiles.20,21 Nevertheless, it is also known from the 
literature that b-sheet forming structures can arise from sequences as short as 2 
amino acids, as in the case of Fmoc–diphenylalanine peptide self-assembly.22,23  
 
The hydrophilic positively-charged block is the only segment that was different 
between the two structures and we believe the critical parameter determining the 
physico-chemical differences between the two PNF systems. The hydrophilic block 
in both peptide amphiphile structures was designed to be positively charged by the 
inclusion of basic amino acids. Charged PNFs can repel each other minimizing the 
aggregation in the system. Roberts et al.24 have shown that for b-sheet forming 
peptides the net charge of the system, or charge modulus, has to be greater than 1 
so that the electrostatic repulsion can prevent fiber aggregation, independent of the 
sign of the charge. The choice of making the system positively charged rather than 
negatively charged was based on the consideration that most of the nanoparticles 
designed for intracellular delivery purposes should be positively charged, to favour 
the interaction with the moderately negatively charged cell surfaces. 
One of the two peptides was assigned a positive charge by incorporating an 
arginine (R) at the C-terminus, while the other peptide was engineered by 
incorporating three peptides, lysine, arginine and lysine (KRK). The molecular 
structures of the two peptides are shown schematically in Fig. 1(A and D) and they 
will be referred to throughout the text as peptides R and KRK, respectively. In the 
case of peptide R, final PNFs with a modest positive charge were aimed for, while 
in the case of peptide KRK, highly positively charged PNFs were studied. Both 
peptides included in their sequence the highly basic residue arginine, that is often 
found in dense protein patches and is able to form bidentate hydrogen bonds as a 
consequence of the charge delocalization on the guanidinium group.25 
Oligopeptides incorporating an arginine headgroup have been reported to undergo 
self-assembly into nanosheets26 and nanofibrils.27 
After sonication we could observe that the PNF dispersion of the less positive 
peptide amphiphile (peptide R) was translucent, due to the Tyndall effect (inset in 
Fig. 1F). The PNF dispersion prepared with the KRK peptide was transparent 
(inset in Fig. 1C). We then studied the morphology of the PNFs by SAXS to 
characterize the shape and the dimensions of the nanostructures. Fig. 1B shows 
the scattering pattern of the KRK PNFs in 5% dextrose at 25 °C together with the 
best fit of a core–shell cylindrical model. There is a medium range shoulder centred 
at 0.9 nm-1 and an increase of intensity at small q. 
The fitting of the core–shell model adequately captures the essence of the 
experimental scattering. The parameters of the fits correspond to 5.2 ± 0.6 nm for 
the outer radius and 4.4 ± 0.4 nm for the inner radius. According to the determined 
electron densities of the core and shell (306 e nm-3 for the core and 346 e nm-3 for 
the shell), there should be significant presence of high electron density atoms 
(nitrogen and oxygen as compared to the low electron density hydrocarbon chains) 
in the cores of the cylinders. The whole picture is consistent because, if only 
hydrocarbon chains were in the core, this should have a maximum radius of about 
2.0 nm based on the palmitoyl chain length and the electron density of the core 
should be approx. 280 e nm-3. If we account for the maximum length of the 
hydrophobic core as corresponding to the palmitoyl chain plus the hydrophobic 
amino acid chain, this corresponds to approx. 5.6 nm which is enough to be 
accommodated within the determined 4.4 nm. The length of the cylinders lies out of 
our SAXS window and we can only estimate a minimum length of 100 nm. 
The Guinier analysis in the small q regime corresponds to only 7 nm radius for 
globular aggregates and the cylinder form of the Guinier analysis produces a 3.2 
nm cylinder radius and 38 nm cylinder length. This could explain part of the 
difference with the R peptide amphiphile whose charge corresponds only to the 
terminal arginine group which at neutral pH should bear both positive and negative 
charges. The SAXS result is shown in Fig. 1E. In this case the intensity grows 
faster at small q and also the shoulder at intermediate q is more evident than for 
the case of KRK. This is partially due to stronger segregation of the hydrophilic and 
hydrophobic moieties of the peptide amphiphile. The cylinder core radius 
corresponds to 0.8 ±0.2 nm while the outer radius is similar to that of KRK, 5.2 ± 
0.4 nm. The core electron density is 299 e nm-3 while the shell electron density is 
342 e nm-3. The cylinder length is also out of the observation window and can be 
estimated as more than 100 nm. In this case, the Guinier analysis produces an 
estimated globular radius of 32 nm (clearly excessive) and cylindrical estimates of 
9 nm for the radius and 64 nm for the length of the PNFs, in agreement with the 
fitted values.28  
Similar peptide amphiphile solutions have also been studied previously using 
SAXS. Long fibril-forming systems, as determined by optical techniques, tend to 
show q-1 behaviour at small q values while the presence or absence of shoulders at 
intermediate q values is determined by the specific contrast variation across the 
cylinder section. The q-1 behaviour at small q can also be obscured by the specific 
contrast variation, as shown by the fitting obtained for KRK or by interparticle 
effects.29 The tendency to form cylindrical aggregates at low concentrations can be 
considered a property of peptide amphiphiles and is probably promoted by the 
presence of intermolecular hydrogen bonding. Indeed, the formation of micelles at 
low concentration of peptide amphiphiles has been demonstrated in both single 
chain30 and gemini lipoaminoacid surfactants.10 
The structure analysis performed using transmission electron microscopy shows 
that peptide R (Fig. 1F), could assemble into short PNFs with a rod-like stiff 
structure and a formulation resulting in a highly light-scattering suspension. Peptide 
KRK formed more flexible elongated nanofibers (Fig. 1C). Taken together, this 
information supports the hypothesis that surface charge is an important factor to be 
considered for the fabrication of PNFs that could be designed for the transport of 
various molecules. 
Peptide nanofibers are commonly considered biodegradable because they consist 
of amphiphilic peptides and peptides that can be enzymatically degraded by 
endogenous peptidases via hydrolysis of the amidic bond formed between amino 
acids. Nevertheless, adjacent peptide amphiphiles can form H-bonds at the level of 
their ß-sheet forming sequences. 
We postulate that enzymatic degradation may occur in two different ways: a) the 
enzyme can dissociate the PNFs into smaller fragments, or b) the disassembly 
may occur from the two ends towards the centre, as the single peptide units are 
cleaved to result in the shortening of the PNFs (Fig. 4). In both cases, the enzymes 
can hydrolyse the peptidic bonds between two amino acids and break down each 
peptide amphiphile monomer into its amino acid constituents. Peptidases can 
cleave the amino acids either by hydrolysis of the amide bond starting from the N-
terminus (aminopeptidases) or by hydrolysis from the C-terminus 
(carboxypeptidases). In the two peptide amphiphiles the N-terminus was 
chemically modified via the attachment of the palmitoyl chain and these 
hydrophobic chains were packed to form the lipophilic core of these 
nanostructures, making this site not readily available to aminopeptidases. 
Furthermore the ß-sheet forming peptides are involved in the formation of the H-
bonds, also inaccessible to enzymes. The C-terminus will be available to enzymes, 
since it is part of the hydrophilic head group, exposed towards the aqueous 
environment. Carboxypeptidases should be able to interact with the C-terminus 
and act to hydrolyse the amino acids. 
To test this hypothesis we decided to study the PNF degradation as a function of 
UV absorbance by incorporation of a probe. We modified the peptides using 
VivoTag 680 XL by the formation of an ester link between the amino group on the 
peptide side chains (K and R) of the basic amino acids and the N-
hydroxysuccinimide of the probe molecule. The reaction with peptide R resulted in 
the formation of a highly hydrophobic peptide that precipitated into an insoluble 
product. This was due to the chemical modification of the basic R leading to the 
neutralization of its positive charge. Modification of peptide KRK was successful 
and the conjugate was well dispersed in 5% dextrose, thus PNFs were readily 
prepared using the sonication protocol. 
The fluorescently labelled PNFs were incubated with plasma (plasma : PBS = 1 : 1) 
and the UV-vis absorbance measured to estimate the structural integrity over ten 
days (Fig. 2). There was an intensity decrease of about 10–15% in the first 6 days, 
and it was indicated that the structural integrity of the PNFs was reduced by 50% in 
7 days and it reached about 33% after 14 days of incubation. At 21 days the 
absorbance was below the limit of detection, thus the value measured for the 
absorbance was not considered reliable. These data suggest that circulating 
peptidases present in plasma were able to metabolize the PNFs. 
The KRK PNFs were then incubated in 0.05% trypsin–EDTA. Trypsin was chosen 
as a model carboxypeptidase to test the hypothesis that they can degrade PNFs. 
Samples were imaged using TEM at different time points to observe any structural 
change and length variation that may occur during the enzymatic degradation 
process (Fig. 3A). 30 min post-incubation the PNFs had a stable structure. The 
semi-quantitative image analysis of the TEM images (Fig. 3B) shows that already 
after 24 h there is a reduction in the length of the nanofibers. There continues to be 
an overall reduction of the PNFs after 48 h with the size distribution widening, 
perhaps due to the coalescence of smaller fibers (Fig. 3A). At 14 days the PNFs 
were very hard to identify by TEM. 
Previous studies have reported that peptide nanofiber gels designed to incorporate 
a proteolytic sequence incubated with collagenase IV in HEPES-buffered saline 
solution were completely degraded after one month.31 Enzyme attack at multiple 
sites can also perturb the assembly into nanofibers and H-bond breaks can 
increase the molecular mobility of the peptides resulting in a more disordered 
packing. Furthermore, as the H-bonds are broken the sites for enzymatic 
degradation are less sterically hindered and amino acids can be cleaved easier. 
KRK PNFs were also incubated in cell culture media (MEM) that did not contain 
any enzyme. No signs of degradation were observed, however PNFs showed in 
cell media a tendency toward aggregation overtime (Fig. 3C). This could be 
attributable to a buffering effect of the ions present in the cell medium on the 
positive charges on the PNF surface and to electrostatic interactions with other 
amino acid constituents in the media. From these in vitro assays we could 
conclude that PNFs were structurally unstable in biological media that contained 
enzymes. Moreover, the enzyme-mediated disassembly process seemed to favour 
the mechanism II in Fig. 4, first evidenced by PNF length reduction, and then 
structural degradation. 
We then investigated how KRK PNFs interacted with living cells. To study the 
cellular internalization, KRK nanofibers were labelled with Nile Red, an 
hydrophobic dye, encapsulated into the nanofiber hydrophobic core. This time a 
fluorescent dye not covalently linked to the PNF was preferred in order to leave the 
positive charges on the PNF surface free to interact with the cell surface. Then, the 
tagged nanofibers were incubated with cultured primary neurons isolated from the 
striatum of rat brains for 24 h and the cells were examined by light and 
fluorescence microscopy, as shown in Fig. 5A. The fluorescence signal in the 
cytoplasm of the primary neurons demonstrated that the interaction of the 
positively charged PNFs with the cell surface results in internalization of the PNFs. 
The fiber shaped PNFs may offer an additional cell entrance gate by energy-
independent internalisation mechanisms, similar to other high axial ratio 
nanostructures that have been previously described to pierce the plasma 
membrane.32 
In this context, PNFs may offer the ideal platform as a nanocarrier because of the 
versatility with which they can be engineered. They can be employed as carriers 
for small hydrophobic molecules,33 and at the same time potentially show more 
versatility as a fiber-shaped transporter. PNFs also seem to be degradable in 
biological environments, so we decided to perform a pilot in vivo degradability 
study. PNFs have been shown to be biocompatible scaffolds for neuronal 
differentiation34 and have been investigated as carriers of bioactive molecules to 
the CNS.15 However, PNFs structurally resemble in shape amyloid fibrils, misfolded 
protein aggregates that are involved in a number of neuropathologies associated 
with neurodegeneration.35  
For these reasons we decided to study the residence time of the PNFs injected 
directly in the brain parenchyma, as an initial step towards assessment of the 
safety of this approach for CNS therapeutic delivery. A variety of peptidases have 
been detected in the tissues of the CNS, some of these are membrane bound and 
others are soluble and exist in the highest concentration in the neural cell cytosol.36 
Carboxypeptidases are present in the brain and CSF37 and are responsible for the 
enzymatic degradation of peptides starting from the C-terminus. We studied the 
residence time of the VivoTag 680 XL fluorescently labelled KRK PNFs after 
intracranial injection in the caudate–putamen of athymic nude mice. 
The residence time of the PNFs in living animals (under anaesthesia) was 
measured by following the fluorescent signal using an IVIS fluorescence imaging 
camera. A strong fluorescent signal was observed for up to 1 week upon 
intracranial injection. Furthermore, it is worth noting that the signal remained 
located in the right hemisphere, in proximity to the site of injection. After 10 days 
the PNF fluorescent signal exhibited a considerable decrease and was further 
weakened after 15 days. This data suggests that the PNFs were removed or 
degraded in the brain parenchyma. Much further work should be performed in 
continuation of this pilot in vivo study. 
 
Conclusions 
 
This study has demonstrated that PNFs in suspension can be internalized by cells, 
and degraded overtime in enzyme containing biological fluids and possibly by 
enzymes expressed in vivo. We provided here some initial evidence that nano- 
fibers may have a reduced risk of accumulation and prompt further exploration as 
transporters of therapeutic and diagnostic agents to the CNS.  
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Figures  
 
 
 
Fig. 1 (A) Molecular structure of peptide amphiphiles KRK. (B) SAXS pattern for 
KRK PNFs with the best fit of the core–shell cylindrical model. The error bars of the 
points at the right hand side have not been plotted for clarity. The scattering is 
smeared by the detector width and beam size. (C) Transmission electron 
micrograph of KRK PNFs (1 mg mL-1) in 5% dextrose; the inset shows the physical 
appearance (clear solution) of the formulation after probe sonication. (D) Molecular 
structure of peptide amphiphiles R. (E) SAXS pattern for R PNFs with the best fit of 
the core–shell cylindrical model. The error bars of the points at the right hand side 
have not been plotted for clarity. The scattering is smeared by the detector width 
and beam size. (F) Transmission electron micrograph of R PNFs (1 mg mL-1) in 5% 
dextrose; the inset shows the physical appearance (Tyndall effect) of the 
formulation after probe sonication. 
  
 Fig. 2 UV-vis spectroscopy of KRK PNFs. Labelled KRK PNFs were incubated in 
rat plasma–PBS (1 : 1) and measured by UV absorbance. The percentage of intact 
fiber was measured by means of a calibration curve (inset). 
  
 Fig. 3 Degradation of PNFs measured by TEM. (A) TEM images of KRK nanofibers 
incubated with 0.5% trypsin–EDTA; (B) semiquantitative analysis of the TEM 
images; (C) TEM images of KRK PNFs incubated with MEM (negative control). All 
scale bars = 500 nm. 
  
 Fig. 4 Schematic depiction of two proposed mechanisms leading to PNF 
degradation. Degradation of PNF into its amino acidic components by peptidase. 
Mechanism I shows degradation of PNFs by cleavage of amino acids from the fiber 
ends towards the middle. Mechanism II shows degradation of PNFs into shorter 
nanofibers and formation of amorphous aggregates. 
  
  
Fig. 5 (A) Cell internalization of KRK PNFs encapsulating Nile Red by primary 
neurons isolated from rat brain (scale bar = 50 mm); (B) residence time (days) of 
KRK PNFs fluorescently labelled with VivoTag 680 XL injected intracranially in the 
right brain hemisphere (caudate–putamen) in athymic nude mice, imaged with an 
IVIS Lumina camera at 675 nm. 
